SCHEMBL2565620

SCHEMBL2565620

CNC(=O)c1cccc(S(=O)(=O)NC(C)(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
LMNA P02545 3/20 0.59
MAPT P10636 2/20 0.59
RAB9A P51151 2/20 0.59
KDM4E B2RXH2 1/20 0.59
NPC1 O15118 1/20 0.59
HPGD P15428 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
KIF18A Q8NI77 1/20 0.53
HDAC8 Q9BY41 3/20 0.50
HDAC6 Q9UBN7 3/20 0.50
TP53 P04637 1/20 0.48
LOX P28300 1/20 0.48
PTBP1 P26599 1/20 0.48
AKR1C3 P42330 1/20 0.47
HDAC2 Q92769 2/20 0.47
HTT P42858 1/20 0.47
PARG Q86W56 1/20 0.47
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2568223 0.84 KDM4E (0.63) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL31426436 0.84 KDM4E (0.63) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL4598709 0.84 SMN1; SMN2 (0.63) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL12060827 0.84 LMNA (0.63) MEN1KMT2ALMNAMAPTHPGD
SCHEMBL5041352 0.83 LMNA (0.61) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL15612976 0.80 MEN1 (0.61) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL26618147 0.79 LMNA (0.56) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL30643040 0.79 LMNA (0.56) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL7454308 0.79 HDAC8 (0.58) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL4959359 0.79 SMN1; SMN2 (0.63) MEN1KMT2ALMNARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013183-B1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR ALMIRALL SA (ES) 2011-11-02 EP disclosed
US-20090082378-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR LABORATORIOS ALMIRALL, S.A. (ES) 2009-03-26 US disclosed
EP-2013183-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR Laboratorios Almirall, S.A. (ES) 2009-01-14 EP disclosed
WO-2007124898-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR LABORATORIOS, ALMIRALL S.A. (ES) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082378-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR ADRB2, ADRA2C, ADRB1 MEN1 4112/4885KMT2A 2632/4885LMNA 2787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.